Corrigendum to “Evolving strategies and application of proteins and peptides therapeutics in cancer treatment” [Biomed. Pharmacother. 163 (2023) 114832] - 21/05/26
Doi : 10.1016/j.biopha.2026.119314
Anirban Goutam Mukherjee a, Uddesh Ramesh Wanjari a, Abilash Valsala Gopalakrishnan a, ⁎, 1 
, Pragya Bradu a, Antara Biswas a, Raja Ganesan b, Kaviyarasi Renu c, Abhijit Dey d, Balachandar Vellingiri e, Achraf El Allali f, ⁎, 1 , Alsamman M. Alsamman g, Hatem Zayed h, C. George Priya Doss i
, Pragya Bradu a, Antara Biswas a, Raja Ganesan b, Kaviyarasi Renu c, Abhijit Dey d, Balachandar Vellingiri e, Achraf El Allali f, ⁎, 1 , Alsamman M. Alsamman g, Hatem Zayed h, C. George Priya Doss i a Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, India
b Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, South Korea
c Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu 600077, India
d Department of Life Sciences, Presidency University, Kolkata, West Bengal 700073, India
e Stem cell and Regenerative Medicine/Translational Research, Department of Zoology, School of Basic Sciences, Central University of Punjab (CUPB), Bathinda, Punjab 151401, India
f African Genome Center, Mohammed VI Polytechnic University, Ben Guerir, Morocco
g Department of Genome Mapping, Molecular Genetics, and Genome Mapping Laboratory, Agricultural Genetic Engineering Research Institute, Giza, Egypt
h Department of Biomedical Sciences College of Health Sciences, QU Health, Qatar University, Doha, Qatar
i Department of Integrative Biology, School of BioSciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119314- juin 2026 Retour au numéro
Article précédent
- Corrigendum “Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents” [Biomed. Pharmacother. 152 (2022) 113196]
- Bashir Lawal, Saidu Sani, Amos S. Onikanni, Yunusa O. Ibrahim, Abdulhakeem R. Agboola, Halimat Yusuf Lukman, Femi Olawale, Ali A. Jigam, Gaber El-Saber Batiha, Shukurat B. Babalola, Mostafa-Hedeab Gomaa, Clara Mariana Gonçalves Lima, Alexander T.H. Wu, Hsu-Shan Huang, Carlos Adam Conte-Junior
- Corrigendum: "Targeting Nrf2/HO-1 signaling by Crocin: Role in attenuation of acetic acid-induced ulcerative colitis in rats" [Biomed. Pharmacother. 110 (2019) 389–399]
- Ahmed E. Khodir, Eman Said, Hoda Atif, Hassan A. ElKashef, Hatem A. Salem
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?